Page last updated: 2024-12-05

dithiazanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dithiazanine is a thiazine dye that was initially investigated as an antihelminthic agent, primarily against roundworms. It was synthesized in the mid-20th century and found to be effective against various parasitic nematodes in both animals and humans. The compound acts by interfering with the energy metabolism of parasitic worms, disrupting their ability to utilize glucose. While dithiazanine was once widely used, it has largely been replaced by newer, safer, and more effective anthelmintic drugs due to concerns about its potential side effects, including gastrointestinal disturbances, liver damage, and neurotoxicity. However, research into dithiazanine continues to be of interest in the context of developing new antiparasitic agents and understanding the mechanisms of parasite metabolism. Further research is also exploring its potential applications in other areas, such as photodynamic therapy for cancer treatment and as a fluorescent probe for biological imaging.'

Dithiazanine: 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium. A benzothiazole that was formerly used as an antinematodal agent and is currently used as a fluorescent dye. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dithiazanine : A cationic C3-cyanine dye with 3-ethylbenzothiazol-2-yl groups at both ends. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10579
CHEMBL ID1185568
CHEBI ID52787
MeSH IDM0006610

Synonyms (7)

Synonym
3,3'-diethylthiadicarbocyanine
dithiazanine
3-ethyl-2-[5-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzothiazole
CHEBI:52787 ,
CHEMBL1185568
dithiazanine cation
dithiazanine ion
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
anthelminthic drugSubstance intended to kill parasitic worms (helminths).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzothiazoles
benzothiazolium ion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (165)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990151 (91.52)18.7374
1990's3 (1.82)18.2507
2000's6 (3.64)29.6817
2010's4 (2.42)24.3611
2020's1 (0.61)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.40 (24.57)
Research Supply Index5.27 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (3.61%)6.00%
Case Studies5 (2.58%)4.05%
Observational0 (0.00%)0.25%
Other182 (93.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]